tirzepatide vs semaglutide comparison weight loss – 2026 For Expats Tirzepatide vs Semaglutide - GLP-1

Clinical and MR spectroscopy (MRS) data of patients Patient 1 could not tolerate full MAD diet since he was vegan, so he was transitioned to a low glycemic index diet about 2 months into the program, but he continued to consume about two tablespoons (2.5 oz) of MCT oil three times per day

Factors like excess weight, repetitive movement, high impact exercise and diet can all contribute to joint discomfort over time

Tirzepatide, an FDA-approved dual GLP-1/GIP agonist (in Mounjaro/Zepbound), improves insulin sensitivity, glucose uptake, and adiponectin while reducing appetite and ectopic fat

The SURMOUNT program studied tirzepatide for weight management (NEJM, 2022) and SURMOUNT-OSA examined obstructive sleep apnea (NEJM, 2024)